Researchers make ‘significant discovery' in treating prostate cancer — what it means for patients
Looks like Ozempic isn't the only diabetes drug that wound up having a secret side hustle.
A team of Swedish researchers has discovered that a drug traditionally meant for Type 2 diabetes shows immense promise in keeping prostate cancer at bay.
A team of Swedish researchers has discovered that a drug traditionally meant for type 2 diabetes shows promise in keeping prostate cancer at bay.
Peakstock – stock.adobe.com
Advertisement
The research — which was published in the journal Molecular Cancer — was based on studies on mice, as well as a retrospective study of 69 prostate cancer patients with type 2 diabetes, all of whom experienced a lack of cancer recurrence while using the drug.
'This is a significant discovery,' Lukas Kenner, a visiting professor at Sweden's Umeå University, said in a press release.
Advertisement
'For the first time, we have clinical observations showing that prostate cancer patients with diabetes who received drugs targeting the protein [PPARy] remained relapse-free during the period we followed them.'
Pioglitazone — a common anti-diabetic drug — not only slowed down the growth of cancer cells but also hampered their ability to grow back.
'The findings are very promising, but further clinical studies are needed to both confirm the results and to investigate whether the treatment can also be used in patients with prostate cancer who do not have diabetes,' Kenner said.
It's the latest in a series of advances targeting prostate cancer — the second most common cancer among men in the US, after skin cancer.
Advertisement
'This is a significant discovery,' Lukas Kenner said.
jarun011 – stock.adobe.com
A UCLA study found that an AI tool identified prostate cancer with 84% accuracy, compared to 67% by physicians, highlighting the potential of AI in improving diagnostic precision.
A new at-home saliva test analyzes DNA for genetic markers associated with prostate cancer, offering a more accurate alternative to traditional blood tests and aiding in earlier detection.
Advertisement
And — following the shocking news that former President Joe Biden has an 'aggressive' form of prostate cancer — one Manhattan doctor is offering free PSA blood tests at his Midtown East office through the end of June.
While the overall five-year survival rate for prostate cancer is as high as 97%, studies have shown that men who avoid prostate cancer screening appointments are 45% more likely to die from the disease.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
How long does it take weight loss drugs to work?
(NewsNation) — Weight loss medications like Ozempic and Wegovy have become increasingly popular over the past few years. For those who are looking into using a weight loss drug, how fast they work often comes into question. While the timeline for noticeable changes varies from person to person, people have often noticed changes in their appetite and weight within the first few weeks of use. According to the Mayo Clinic, most weight loss occurs within the first four to five months of use. Long-term use of weight loss drugs can lead to sustained weight loss and improvements in overall metabolic health but must be paired with healthy eating and exercise. HHS cancels funding for Moderna vaccines to fight pandemic flu There are a few factors that can contribute to how quickly weight loss drugs can work for each individual, like metabolism and following the treatment plan. People with a higher metabolism are more likely to see results faster from weight loss drugs compared to those with a lower metabolic rate. Lifestyle factors like dietary habits, exercise routines, adequate sleep and stress management also play a role in the speed at which weight loss drugs work. Since the drugs can suppress your appetite, it can be challenging to get proper nutrition and possibly lead to side effects. Doctors say to manage any side effects, you should follow a nutritionally balanced diet and drink enough fluids. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
5 hours ago
- Yahoo
Cheryl Burke begs fans to stop focusing on her appearance as she addresses body image struggles
Cheryl Burke wants people to stop focusing on her body. The 41-year-old dancer - who is best known for having been a professional on 'Dancing with the Stars' - has "done so much work" on her mental health in recent years but feels "gaslit" when met with comments about her physical appearance even though she is aware that she "signed up" for that sort of thing by becoming famous. She told 'Entertainment Tonight': "Let's talk about mental health, let's talk about what I've done as far as the last few years when I haven't been in the spotlight but I've done so much work on myself from the inside out. And I'm proud of that work. I wish the conversation was more geared towards that rather than 'She's on Ozempic, she got a whole face lift and everything about her has changed', gaslighting. "If I were to say that it doesn't affect me, I would be lying but does it affect me as bad as it did when I was on the show? Not even close! It's interesting. I know I've signed up for it, I understand I've signed up for it, and I'm a public figure. I'm not trying to stop anything from happening but I'm just here hopefully to influence anyone who is in a similar position that there is more depth to a human being other than their outside physical appearance." Cheryl - who was married to 'Boy Meets World' star Matthew Lawrence from 2019 until 2022 - has suffered from body dysmoprhia for most of her life, and admitted that it reached its peak when she had to undergo regular fittings during her time on the ABC dance competition and she became obsessed with her weight. She said: "I do suffer from body dysmorphia, especially as a dancer in front of mirrors. Constantly. Since I was a little girl, and this was even before my 'Dancing with the Stars' career. My weight has always been an issue but I think what people sometimes don't understand is it is a lot of work, it takes a lot of work and self-care. The height of my insecurity and my body dysphoria was weekly fittings on the show. I don't blame the show by any means; it's just the name of the game, squeezing into these costumes. It is what it is. But it would affect me to the point where I would travel with a scale. That's crazy on a whole other level and I knew this could no longer continue. The number would affect my every day, and would dictate how I feel."
Yahoo
6 hours ago
- Yahoo
Diabetes Canada stresses it doesn't endorse medical products after ads suggest otherwise
Diabetes Canada says it's received a surge in reports from people who've seen ads for or bought products that use the charity's logos without authorization. Since January, Diabetes Canada says it's had over 300 calls to its 1-800 line and emails from people reporting misleading advertisements for diabetes products that have the charity's logo. Diabetes Canada isn't the only organization being affected. Products ranging from purported medications and supplements to devices that claim to be blood glucose monitors are also carrying the logos of Obesity Canada and Health Canada. Some of the groups say they want the ads taken down and social media companies are doing that, but new ads keep appearing. A class of injectable medications known as GLP-1 agonists, sold in Canada under the brand name Ozempic and Wegovy are approved to treat Type 2 diabetes and obesity, respectively. These drugs need to be administered by doctors and distributed by pharmacists. They are also not endorsed by Diabetes Canada, Obesity Canada or Health Canada. Some of the misleading ads are for products that doctors say are not effective but mimic the names of these more recognizable medications. These include GLP-1 oral drops, said Laura Syron, the president and CEO of Diabetes Canada. "They're certainly not endorsed by us," Syron said on Thursday. "We do not endorse any medical health product." Doctors say it's important for people who live with diabetes to get accurate blood sugar readings. That's why Syron recommends anyone considering changing their medication, trying a new treatment or getting a new monitoring device talk to their health-care provider first. The organization said some ads falsely claim the organization will also offer patients a subsidy. Use of logo created sense of trust Joel Snitman, 81, of Thornhill, Ont., has Type 2 diabetes and checks his blood sugar levels at least once a week. Snitman said he saw a Facebook ad for a product with a photo identifying it as a glucose monitor. He said he trusted it because the ad showed Diabetes Canada's logo. "This gadget offered to do it without sticking a needle in your finger," Snitman recalled. "I thought I would give it a shot." The product turned out to be an oximeter, a device used to measure blood oxygen levels, not blood sugar. Snitman contacted Diabetes Canada, saying he felt he got sucked in by seeing their logo on the ad. He said he wasn't able to find the name of the manufacturer or retailer beyond a series of consonants. He emailed the delivery company and asked them if they knew their client. The answer was no. Similarly, Syron said Diabetes Canada found it difficult to get in touch with anyone at the company. CBC News was also unable to contact the company. Concerns about delayed treatment Dr. Kaberi Dasgupta, a physician, scientist and professor of medicine at McGill University, says there are no drops or patches that would give a similar effect to GLP-1 medications, which need to be administered by doctors and distributed by pharmacists. "Those products, the GLP-1 patches and drops, they're just trying to … join the enthusiasm and kind of, I would say madness, surrounding these medications that certainly can enhance weight reduction and can improve blood sugar control in diabetes," Dasgupta said from Halifax. Her concern is that if someone with diabetes uses the drops or patches, it could delay or prevent them from receiving proper medical care. Talia Wiebe, director of marketing and communications at Obesity Canada, says the organization is aware of a company fraudulently using Obesity Canada's name, logo and an image of its founder, Dr. Arya Sharma, to promote an unregulated supplement called HHVB GLP-1 Moringa Slimming & Health Boost Drops. Obesity Canada tried to find the supplement maker without success. "We are working with our legal team to hopefully reach out to them and cease and desist and have these products taken down," Wiebe said. Diabetes Canada says it has reached out to various social media platforms where the ads using their logo have appeared and reported the issue to Health Canada. "All medical devices authorized for use in Canada are listed in the Medical Devices Active Licence Listing database," a spokesperson for Health Canada said. A search of Remifa or Briskix, the product and seller of Snitman's purchase, did not yield any results. Syron added another challenge is that when one ad disappears, another quickly pops up. A spokesperson for Meta, which owns Facebook and Instagram, said Friday that it has removed the ad from its platforms and is continuing to investigate. Meta says its policies prohibit content that "defrauds people by promoting false or misleading health claims, including those related to weight loss, and we remove this kind of content when we become aware of it." Meta also notes that the challenge spans platforms, industries and communities, which is why it works with law enforcement, regulators and private industry to combat scams. "We continue to invest resources and further improve our enforcement on this kind of content," the spokesperson said. Health Canada did not respond to CBC News regarding the use of its name on some advertisements.
